The effect of moderate and high alcohol consumption on the response to HCV treatment and the progression of chronic HCV infection.
- Prosjektnummer
- 2009046
- Ansvarlig person
- Kirsten Muri Boberg
- Institusjon
- Oslo universitetssykehus HF
- Prosjektkategori
- Postdoktorstipend
- Helsekategori
- Infection
- Forskningsaktivitet
- 5. Treatment Developement
CMV drives clonal expansion of NKG2C+ NK cells expressing self-specific KIRs in chronic hepatitis patients.
Eur J Immunol 2012 Feb;42(2):447-57. Epub 2011 des 16
PMID: 22105371
A systematic review of hepatitis C virus epidemiology in Europe, Canada and Israel.
Liver Int 2011 Jul;31 Suppl 2():30-60.
PMID: 21651702
Management of adverse effects of Peg-IFN and ribavirin therapy for hepatitis C.
Nat Rev Gastroenterol Hepatol 2011 Apr;8(4):212-23. Epub 2011 mar 8
PMID: 21386812
IL28B genetic variation and treatment response in patients with hepatitis C virus genotype 3 infection.
Hepatology 2011 Mar;53(3):746-54.
PMID: 21374656
Liver fibrosis in hepatitis C patients of Pakistani versus Scandinavian origin.
Scand J Gastroenterol 2010 Dec;45(12):1503-8. Epub 2010 aug 10
PMID: 20698740
Ribavirin dosage in patients with HCV genotypes 2 and 3 who completed short therapy with peg-interferon alpha-2b and ribavirin.
Aliment Pharmacol Ther 2010 Jun;31(12):1346-53. Epub 2010 mar 8
PMID: 20222909
In patients with HCV genotype 2 or 3 infection and RVR 14 weeks treatment is noninferior to 24 weeks. Pooled analysis of two Scandinavian trials.
Eur J Gastroenterol Hepatol 2010 May;22(5):552-6.
PMID: 20154627
IL28B genetic variation and treatment response in patients with HCV genotype 3 infection.
Hepatology nov 2010 (abstract)
LOW-TO-MODERATE ALCOHOL CONSUMPTION HAS NO IMPACT ON ANTIVIRAL RESPONSE TO COMBINATION THERAPY IN HCV PATIENTS WITH GENOTYPE 2 O
Hepatology, november 2009 (abstract AASLD 2009)
- Olav Dalgard Postdoktorstipendiat
eRapport er utarbeidet av Sølvi Lerfald og Reidar Thorstensen, Regionalt kompetansesenter for klinisk forskning, Helse Vest RHF, og videreutvikles av de fire RHF-ene i fellesskap, med støtte fra Helse Vest IKT
Alle henvendelser rettes til eRapport